Back

Single-nucleus RNA-sequencing reveals novel potential mechanisms of ovarian insufficiency in 45,X Turner Syndrome

McGlacken-Byrne, S. M.; Del Valle, I.; Xenakis, T.; Suntharalingham, J. P.; Nel, L.; Liptrot, D.; Crespo, B.; Ogunbiyi, O. K.; Niola, P.; Brooks, T.; Solanky, N.; Conway, G. S.; Achermann, J. C.

2023-12-23 genomics
10.1101/2023.12.22.572342 bioRxiv
Show abstract

Study questionCan single-nuclei and bulk RNA sequencing technologies be used to elucidate novel mechanisms of ovarian insufficiency in Turner Syndrome (TS)? Summary answerUsing single-nucleus and bulk RNA sequencing approaches, we identified novel potential pathogenic mechanisms underlying ovarian insufficiency in TS including and beyond X chromosome haploinsufficiency. What is known alreadyTurner syndrome (TS) is the most common genetic cause of Primary Ovarian Insufficiency (POI) in humans. Morphological analyses of human fetal 45,X ovaries have demonstrated fewer germ cells and marked apoptosis established by 15-20 weeks post conception (wpc); however, we do not understand why POI develops mechanistically in the first instance. Study design, size, durationSingle-nucleus RNA sequencing (snRNA-seq): two 46,XX and two 45,X (TS) human fetal ovaries at 12-13 wpc. Bulk RNA sequencing: 19 human fetal ovary, 20 fetal testis, and 8 fetal control tissue (n=47 total samples; Carnegie Stage 22-16wpc). Participants/materials, setting, methodsTo identify novel potential mechanisms of ovarian insufficiency in TS and to characterise X chromosome gene expression in the 45,X ovary, we performed snRNA-seq of peri-meiotic 46,XX (n=2) and 45,X (n=2) fetal ovaries at 12-13 weeks post conception (wpc); and 2) a bulk RNA sequencing time-series analysis of fetal ovary, testis, and control samples across four developmental timepoints. Main results and the role of chanceGerm and somatic cell subpopulations were mostly shared across 46,XX and 45,X ovaries, aside from a 46XX-specific/45,X-depleted cluster of oogonia ("synaptic oogonia") containing genes with functions relating to sex chromosome synapsis; histone modification; intracellular protein regulation and chaperone systems. snRNA-seq enabled accurate cell counting localised to individual cell clusters; the 45,X ovary has fewer germ cells than the 46,XX ovary in every germ cell subpopulation, confirmed by histopathological analysis. The normal sequence of X-chromosome inactivation and reactivation is disrupted in 45,X ovaries; XIST was not expressed in 45,X somatic cells but was present in germ cell clusters, albeit with lower expression than in corresponding 46,XX clusters. The 45,X ovary has a globally abnormal transcriptome, with low expression of genes with proteostasis functions (RSP4X); cell cycle progression (BUB1B); and OXPHOS mitochondrial energy production (COX6C, ATP11C). Genes with higher expression in 45,X cell populations were enriched for apoptotic functions (e.g., NR4A1). Limitations, reasons for cautionLimitations include the relatively small sample size of the snRNA-seq analysis and the focus on a fixed meiotic timepoint which may overlook a dynamic process over time. Wider implications of the findingsWe characterise the human fetal peri-meiotic 45,X ovary at single-cell resolution and offer insights into novel pathogenic mechanisms underlying ovarian insufficiency in TS. Although asynapsis due to X chromosome haploinsufficiency likely plays a significant role, these data suggest meiotic failure and ovarian insufficiency may be a combinatorial process characterised by periods of vulnerability throughout early 45,X germ cell development Study funding/competing interest(s)This research was funded in whole, or in part, by the Wellcome Trust Grants 216362/Z/19/Z to SMcG-B and 209328/Z/17/Z to JCA. Human fetal material was provided by the Joint MRC/Wellcome Trust (Grant MR/R006237/1) Human Developmental Biology Resource (http://www.hdbr.org). Research at UCL Great Ormond Street Institute of Child Health is supported by the National Institute for Health Research, Great Ormond Street Hospital Biomedical Research Centre (grant IS-BRC-1215-20012).

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 8%
17.6%
2
Molecular Human Reproduction
11 papers in training set
Top 0.1%
12.4%
3
The American Journal of Human Genetics
206 papers in training set
Top 0.5%
8.5%
4
eLife
5422 papers in training set
Top 17%
4.9%
5
PLOS Genetics
756 papers in training set
Top 3%
4.3%
6
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 20%
3.6%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 41%
3.1%
8
Cell Genomics
162 papers in training set
Top 2%
2.6%
9
Journal of Medical Genetics
28 papers in training set
Top 0.2%
2.4%
10
PLOS Medicine
98 papers in training set
Top 2%
1.9%
11
Human Molecular Genetics
130 papers in training set
Top 2%
1.7%
12
Human Reproduction
18 papers in training set
Top 0.3%
1.7%
13
JCI Insight
241 papers in training set
Top 4%
1.5%
14
Genetics in Medicine
69 papers in training set
Top 0.8%
1.2%
15
Cell Reports
1338 papers in training set
Top 29%
1.0%
16
iScience
1063 papers in training set
Top 24%
1.0%
17
European Journal of Human Genetics
49 papers in training set
Top 1.0%
1.0%
18
Frontiers in Genetics
197 papers in training set
Top 8%
0.9%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
0.9%
20
Communications Biology
886 papers in training set
Top 21%
0.8%
21
Science
429 papers in training set
Top 19%
0.8%
22
Nature Genetics
240 papers in training set
Top 7%
0.8%
23
Nature
575 papers in training set
Top 15%
0.7%
24
PLOS Biology
408 papers in training set
Top 21%
0.7%
25
Current Biology
596 papers in training set
Top 14%
0.7%
26
BMC Biology
248 papers in training set
Top 6%
0.6%
27
EMBO Reports
88 papers in training set
Top 1%
0.5%
28
Nucleic Acids Research
1128 papers in training set
Top 21%
0.5%
29
PLOS ONE
4510 papers in training set
Top 73%
0.5%
30
Genome Research
409 papers in training set
Top 5%
0.5%